89.30
price down icon1.24%   -1.12
after-market 시간 외 거래: 89.32 0.02 +0.02%
loading
전일 마감가:
$90.42
열려 있는:
$89.52
하루 거래량:
687.05K
Relative Volume:
0.55
시가총액:
$10.53B
수익:
$2.77B
순이익/손실:
$286.61M
주가수익비율:
38.00
EPS:
2.35
순현금흐름:
$524.11M
1주 성능:
-0.03%
1개월 성능:
-4.99%
6개월 성능:
-23.48%
1년 성능:
-18.27%
1일 변동 폭
Value
$88.25
$89.76
1주일 범위
Value
$88.25
$93.57
52주 변동 폭
Value
$88.01
$129.50

퍼킨엘머 Stock (RVTY) Company Profile

Name
명칭
Revvity Inc
Name
전화
781-663-6900
Name
주소
77 4TH AVENUE, WALTHAM
Name
직원
11,000
Name
트위터
Name
다음 수익 날짜
2025-04-28
Name
최신 SEC 제출 서류
Name
RVTY's Discussions on Twitter

RVTY을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Diagnostics & Research icon
RVTY
Revvity Inc
89.30 10.87B 2.77B 286.61M 524.11M 2.35
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
396.45 152.34B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
189.27 135.39B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
514.80 41.54B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
111.07 31.59B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
139.06 24.31B 15.50B 1.33B 2.16B 7.34

퍼킨엘머 Stock (RVTY) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-01 업그레이드 UBS Neutral → Buy
2025-01-10 다운그레이드 Bernstein Outperform → Mkt Perform
2024-12-13 업그레이드 BofA Securities Neutral → Buy
2024-10-15 업그레이드 Barclays Equal Weight → Overweight
2024-08-28 개시 Wells Fargo Equal Weight
2024-07-08 개시 Leerink Partners Outperform
2024-06-03 재개 Jefferies Hold
2024-01-16 다운그레이드 UBS Buy → Neutral
2024-01-04 업그레이드 Evercore ISI In-line → Outperform
2023-12-19 개시 Wells Fargo Equal Weight
2023-12-13 개시 Wolfe Research Peer Perform
2023-09-28 개시 Bernstein Outperform
2023-07-19 개시 Raymond James Outperform
2023-05-23 재개 Goldman Buy
모두보기

퍼킨엘머 주식(RVTY)의 최신 뉴스

pulisher
08:48 AM

Revvity (RVTY) Introduces New Mimix Standards for Improved IVD Testing | RVTY Stock News - GuruFocus

08:48 AM
pulisher
08:00 AM

Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows - Business Wire

08:00 AM
pulisher
May 30, 2025

Insider Sell: Michelle Mcmurry-heath Sells 600 Shares of Revvity Inc (RVTY) - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Does The Market Have A Low Tolerance For Revvity, Inc.'s (NYSE:RVTY) Mixed Fundamentals? - Yahoo

May 30, 2025
pulisher
May 28, 2025

Shareholders in Revvity (NYSE:RVTY) are in the red if they invested three years ago - simplywall.st

May 28, 2025
pulisher
May 27, 2025

Revvity Inc (RVTY) Shares Up 3.52% on May 27 - GuruFocus

May 27, 2025
pulisher
May 25, 2025

RVTY Stock Falls Despite the Latest Launch of Automated Instrument - MSN

May 25, 2025
pulisher
May 23, 2025

Revvity’s EUROIMMUN unveils new fully automated instrument for specialty testing - SelectScience

May 23, 2025
pulisher
May 22, 2025

Enhancing Laboratory Efficiency with Revvity's IDS i20™ Platform - Lab Manager

May 22, 2025
pulisher
May 22, 2025

Is Wall Street Bullish or Bearish on Revvity Stock? - inkl

May 22, 2025
pulisher
May 22, 2025

Is Wall Street Bullish Or Bearish On Revvity Stock? - Barchart.com

May 22, 2025
pulisher
May 22, 2025

Revvity (RVTY) Receives Affirmed Buy Rating with Promising Outlo - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Revvity (RVTY) Receives Affirmed Buy Rating with Promising Outlook | RVTY Stock News - GuruFocus

May 22, 2025
pulisher
May 21, 2025

Sustainable chemistry in India fueling growth with digital and AI innovation: Revvity Signals - Indian Chemical News

May 21, 2025
pulisher
May 20, 2025

Revvity announces launch of new fully automated instrument for specialty testing - BioSpectrum India

May 20, 2025
pulisher
May 19, 2025

Revvity's EUROIMMUN Unveils New Fully Automated Instrument for S - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Revvity's EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing | RVTY Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing - Business Wire

May 19, 2025
pulisher
May 19, 2025

Revvity's New Automated Platform Transforms Specialty Disease Testing with 20-Analyte Capability - Stock Titan

May 19, 2025
pulisher
May 16, 2025

Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch

May 16, 2025
pulisher
May 14, 2025

Revvity Signals Software Inc. v. Cloud Software Group Inc. - Cornerstone Research

May 14, 2025
pulisher
May 14, 2025

Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

May 14, 2025
pulisher
May 14, 2025

Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight - GlobeNewswire Inc.

May 14, 2025
pulisher
May 14, 2025

Shareholders Will Be Pleased With The Quality of Revvity's (NYSE:RVTY) Earnings - Yahoo

May 14, 2025
pulisher
May 13, 2025

Revvity at Bank of America 2025 Healthcare Conference: Navigating Tariffs and Growth - Investing.com India

May 13, 2025
pulisher
May 13, 2025

Revvity To Present At Bank Of America Global Healthcare Conference 2025; Webcast At 12:20 PM ET - Nasdaq

May 13, 2025
pulisher
May 12, 2025

Revvity beats quarterly estimates on steady demand for medical equipment - MSN

May 12, 2025
pulisher
May 12, 2025

Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

RVTY Q1 Earnings Call: Resilient Performance Amid Academic and Tariff Headwinds, Software and Diagnostics Shine - Yahoo Finance

May 12, 2025
pulisher
May 09, 2025

Revvity: Despite Facing Multiple Headwinds, Shares Are A Buy (NYSE:RVTY) - Seeking Alpha

May 09, 2025
pulisher
May 07, 2025

High Content Screening Market Global Forecasts 2025-2030 - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

High Content Screening Market Global Forecasts 2025-2030 with Danaher, Revvity, BD, Carl Zeiss, Merck, and Thermo Fisher Scientific Dominating the $2.19 Billion Market - Yahoo Finance

May 07, 2025
pulisher
May 06, 2025

Revvity joins peers Thermo Fisher, Danaher in tariff warning, maintains profit outlook - MSN

May 06, 2025
pulisher
May 05, 2025

Revvity Announces Financial Results for the First Quarter of 2025 - ADVFN

May 05, 2025
pulisher
May 02, 2025

UBS Upgrades Revvity (BMV:RVTY) - Nasdaq

May 02, 2025
pulisher
May 02, 2025

UBS Upgrades Revvity (BIT:1RVTY) - Nasdaq

May 02, 2025
pulisher
May 02, 2025

UBS lifts Revvity stock rating to Buy, cuts price target to $115 - Investing.com Australia

May 02, 2025
pulisher
May 02, 2025

UBS Upgrades Revvity (LSE:0KHE) - Nasdaq

May 02, 2025
pulisher
May 01, 2025

UBS Upgrades Revvity (RVTY) - Nasdaq

May 01, 2025
pulisher
May 01, 2025

UBS Boosts Revvity (RVTY) Rating to Buy Amid Growth Prospects | - GuruFocus

May 01, 2025
pulisher
May 01, 2025

UBS lifts Revvity stock rating to Buy, cuts price target to $115 By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

UBS Upgrades Revvity to Buy from Neutral, Cuts Price Target to $115 From $145 - marketscreener.com

May 01, 2025
pulisher
May 01, 2025

UBS Boosts Revvity (RVTY) Rating to Buy Amid Growth Prospects | RVTY Stock News - GuruFocus

May 01, 2025
pulisher
Apr 30, 2025

Revvity to Present at Upcoming Investor Conferences | RVTY Stock News - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

KeyBanc Adjusts Revvity's Price Target to $135 From $145 - marketscreener.com

Apr 30, 2025
pulisher
Apr 30, 2025

Revvity CEO and CFO to Share Strategic Vision at BofA and Goldman Sachs Healthcare Conferences - Stock Titan

Apr 30, 2025
pulisher
Apr 30, 2025

Revvity Reports Strong Q1 2025 Financial Results - TipRanks

Apr 30, 2025
pulisher
Apr 29, 2025

Revvity reaffirms 2025 guidance with $4.90-$5 EPS target amid robust software growth - MSN

Apr 29, 2025
pulisher
Apr 29, 2025

Stifel maintains Revvity stock Hold rating, $120 target By Investing.com - Investing.com Canada

Apr 29, 2025

퍼킨엘머 (RVTY) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
diagnostics_research DGX
$174.46
price up icon 0.62%
diagnostics_research WAT
$343.86
price down icon 1.65%
diagnostics_research LH
$247.89
price down icon 0.43%
$160.69
price up icon 1.69%
diagnostics_research MTD
$1,140.83
price down icon 1.54%
diagnostics_research IQV
$139.06
price down icon 0.91%
자본화:     |  볼륨(24시간):